Code | 8348C | ||||||||||
MA number | 29/0210/18-S | ||||||||||
Product Form: | tbl 70x150 mg (fľ.skl.hnedá) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Egis Pharmaceuticals PLC, Hungary | ||||||||||
Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | brown glass bottle | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 04.07.2018 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
PIL: |
|
SPC: |
|
Safety feature | Yes |
Data update: | 15.04.2024 |